Gerresheimer and Aptar Digital Health, an expert in ‘software as a medical device’ (SaMD), digital patient support programs (PSPs) and disease management solutions, collaborate to develop an integrated solution for cancer therapy management. As part of this collaboration, the “Gx SensAir”-on-body drug delivery device...
Large area for small series: Gerresheimer is expanding the capacity of its small series production in Wackersdorf. With the third expansion of the technical competence centre and small batch production at the site in the last five years, the company is taking the next strategic step into the future. The new "Small...
Gerresheimer continues on its growth path and reports a good half-year result. Sales grew organically by around 17 percent excluding currency effects and reached €957 million. Following the successful realignment of the product mix, the company is clearly benefiting from global megatrends in the pharma and biotech...
Gerresheimer achieved double-digit growth in sales and operating result in the financial year 2022. Sales increased organically by 16.2 percent to more than €1.8 billion, driven by all divisions. Operating profit grew organically by 10.2 percent to 338.4 million euros. Adjusted net profit for fiscal 2022 amounted to €...
At the Capital Markets Day “Generating Sustainable Value”, Gerresheimer, a leading provider of healthcare & beauty solutions and drug delivery systems for pharma, biotech and cosmetics, reaffirmed its growth agenda and increased its revenue and adjusted Ebitda guidance. The company continues to execute consistently...
Gerresheimer and Stevanato Group announce that they have jointly developed a high-end ready-to-use (RTU) solution platform with an initial focus on vials, based on Stevanato Group’s market-leading EZ-fill technology. This collaboration is projected to help customers gain efficiencies, improve the quality standard,...
Pharma and medical technology specialist Gerresheimer has established small series production at its Technical Competence Center at its Peachtree City, Georgia location. Small quantities of products can now be manufactured under series conditions and in ISO class 8 cleanroom. During the development and approval of...
Drugs are not meant to fall into children’s hands. But just in case this ever does happen, it is crucial to prevent children from being able to open the containers by securing them with child-resistant caps. That is why more and more customers are choosing child-proof packaging options from Gerresheimer. Gerresheimer...
Gerresheimer's website is now also available in Chinese. As demand for Gerresheimer's innovative and sustainable packaging solutions and drug delivery devices is also growing significantly in China and the company has six production sites in China, Gerresheimer wants to make it easier for its Chinese customers to...
With modern and sustainable glass production technology, Gerresheimer's plants in Germany set exemplary standards for all of the company's plants in Europe, America and Asia, particularly in innovations for greater sustainability. With the use of hybrid technology, the Gerresheimer plant in Lohr plans to build a glass...
